Ekso Bionics (EKSO) Reports Q4 Loss of $0.15/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Ekso Bionics Reports Fourth Quarter and Year End 2017 Results
March 13, 2018 4:05 PM EDTRICHMOND, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and twelve months ended December 31, 2017.
Recent Highlights and Accomplishments
Shipped 21 EksoGT systems in the fourth quarter of 2017 including six rental units. In addition, converted four previously rented units to a sale. This brings total placements to 277, of which 17 are rentals. A 49% increase year-over-year in Ekso GT systems shipped, with 61 Ekso GT systems in 2017. A... More